Zhao Jing, Jin Ke-Ke, Wu Liang, Chen Guo-Rong, Li Jian-Min
Department of Pathophysiology, Wenzhou Medical College, Wenzhou 320035, China.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2012 Sep;28(5):467-71.
To investigate the effect of extract of Ginkgo Biloba(EGB) on nerve growth factor(NGF) and Neurotrophin-3(NT-3) expression of hippocampus neurons in streptozotocin-induced type I diabetic rats.
Thirty male SD rats were divided into three groups (n = 10): the control group, diabetic group and EGB-treated group. Strepozotocin were injected intraperitoneally in the later two groups to induce diabetes. EGB-treated group was injected intraperitoneally with EGB, and the same volume of normal saline was injected to the other groups. Concentration of blood glucose and body weight and behaviour were dynamicly monitored. At the end of the 12th week, morphological changes of the hippocampus neurons were observed under microscopy by HE stain. The expression of NGF and NT-3 were assayed by Western blot and RT-PCR respectively.
Compared with diabetic group, the behaviour and body weight (P < 0.05) and the concentration of blood glucose (P < 0.05) were significantly improved and the escape latency of Morris water maze test (P < 0.05) was significantly shortened, while the platform searching score was significantly increased (P < 0.01) in EGB treated group; The pathological changes of hippocampus neurons were significantly attenuate by EGB treated; The expression of NGF and NT-3 in hippocampus neurons were significantly increased which assayed by Western blotting and RT-PCR respectively (P < 0.05) in EGB treated group.
EGB may improve the learning and memory ability of diabetic rats the mechanism may be attributed to its improvement of the expression of NGF and NT-3 and reducing apoptosis in hippocampus neurons.
探讨银杏叶提取物(EGB)对链脲佐菌素诱导的Ⅰ型糖尿病大鼠海马神经元神经生长因子(NGF)和神经营养因子-3(NT-3)表达的影响。
30只雄性SD大鼠分为三组(n = 10):对照组、糖尿病组和EGB治疗组。后两组腹腔注射链脲佐菌素诱导糖尿病。EGB治疗组腹腔注射EGB,其他组注射等量生理盐水。动态监测血糖浓度、体重和行为。第12周结束时,通过HE染色在显微镜下观察海马神经元的形态变化。分别通过蛋白质免疫印迹法和逆转录-聚合酶链反应检测NGF和NT-3的表达。
与糖尿病组相比,EGB治疗组的行为和体重(P < 0.05)以及血糖浓度(P < 0.05)显著改善,Morris水迷宫试验的逃避潜伏期显著缩短(P < 0.05),而平台搜索得分显著增加(P < 0.01);EGB治疗可显著减轻海马神经元的病理变化;通过蛋白质免疫印迹法和逆转录-聚合酶链反应分别检测,EGB治疗组海马神经元中NGF和NT-3的表达显著增加(P < 0.05)。
EGB可能改善糖尿病大鼠的学习和记忆能力,其机制可能归因于其改善NGF和NT-3的表达以及减少海马神经元凋亡。